Suppr超能文献

基于人群的癌症筛查中的知情决策与能力

Informed Decision-Making and Capabilities in Population-based Cancer Screening.

作者信息

Bolt Ineke L L E, Schermer Maartje H N, Bomhof-Roordink Hanna, Timmermans Danielle R M

机构信息

Department of Medical Ethics, Philosophy & History of Medicine, Erasmus MC, Rotterdam, The Netherlands.

Department of Public and Occupational Health, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

Public Health Ethics. 2022 Oct 3;15(3):289-300. doi: 10.1093/phe/phac023. eCollection 2022 Nov.

Abstract

Informed decision-making (IDM) is considered an important ethical and legal requirement for population-based screening. Governments offering such screening have a duty to enable invitees to make informed decisions regarding participation. Various views exist on how to define and measure IDM in different screening programmes. In this paper we first address the question which components should be part of IDM in the context of cancer screening. Departing from two diverging interpretations of the value of autonomy-as a right and as an ideal-we describe how this value is operationalized in the practice of informed consent in medicine and translate this to IDM in population-based cancer screening. Next, we specify components of IDM, which is voluntariness and the requirements of disclosure and understanding. We argue that whereas disclosure should contain all information considered relevant in order to enable IDM, understanding of basic information is sufficient for a IDM. In the second part of the paper we apply the capability approach in order to argue for the responsibility of the government to warrant equal and real opportunities for invitees for IDM. We argue that additional conditions beyond mere provision of information are needed in order to do so.

摘要

知情决策(IDM)被视为基于人群的筛查的一项重要伦理和法律要求。提供此类筛查的政府有责任让被邀请者能够就参与做出知情决策。对于如何在不同的筛查项目中定义和衡量IDM存在各种观点。在本文中,我们首先探讨在癌症筛查背景下,IDM应包含哪些组成部分这一问题。从对自主性价值的两种不同解释——作为一种权利和作为一种理想出发,我们描述了这种价值在医学知情同意实践中是如何实施的,并将其转化为基于人群的癌症筛查中的IDM。接下来,我们明确了IDM的组成部分,即自愿性以及披露和理解的要求。我们认为,虽然披露应包含所有被认为相关的信息以实现IDM,但对基本信息的理解对于IDM来说就足够了。在本文的第二部分,我们运用能力方法来论证政府有责任确保被邀请者有平等和真正的机会进行IDM。我们认为,为此需要除了单纯提供信息之外的其他条件。

相似文献

1
Informed Decision-Making and Capabilities in Population-based Cancer Screening.基于人群的癌症筛查中的知情决策与能力
Public Health Ethics. 2022 Oct 3;15(3):289-300. doi: 10.1093/phe/phac023. eCollection 2022 Nov.
6
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
7
To Consent or Not to Consent to Screening, That Is the Question.同意还是不同意筛查,这是个问题。
Healthcare (Basel). 2023 Mar 30;11(7):982. doi: 10.3390/healthcare11070982.
10

本文引用的文献

4
Capability Sensitive Design for Health and Wellbeing Technologies.健康与幸福技术的能力敏感设计。
Sci Eng Ethics. 2020 Dec;26(6):3363-3391. doi: 10.1007/s11948-020-00275-5. Epub 2020 Nov 18.
5
Non-maleficence and the ethics of consent to cancer screening.不伤害原则与癌症筛查同意的伦理学
J Med Ethics. 2020 Sep 21;47(7):510-3. doi: 10.1136/medethics-2020-106135.
7
Autonomous and informed decision-making: The case of colorectal cancer screening.自主和知情决策:以结直肠癌筛查为例。
PLoS One. 2020 May 29;15(5):e0233308. doi: 10.1371/journal.pone.0233308. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验